Skip to the page content
Your donations
Passes our checks

AIDS Vaccine Advocacy Coalition Inc

EIN 94-3240841 · New York, NY

Public records show a registered, tax-exempt organization in good standing.

LegitimacyPassesRegistration and standingFinancial healthWeak41 out of 100GovernanceStrong100 out of 100Impact evidenceDescribes programsHow well its results are evidenced

What it says it does

ACCELERATE THE ETHICAL DEVELOPMENT OF EFFECTIVE HIV PREVENTION OPTIONS AND ENSURE ACCESS TO THOSE OPTIONS FOR EVERYONE WHO NEEDS THEM AS PART OF A COMPREHENSIVE INTEGRATED PATH TO GLOBAL HEALTH EQUITY.

Income
$10.0 million
Spending
$13.8 million
Spent on programs
81%
Reserves
2.6 months of spending
Largest source of income
government grants, 55%
Employees
37
Volunteers
0
Highest pay
$448,315, executive director

Source: Form 990 for the year ending December 31, 2024, filed with the Internal Revenue Service. Rating method 2026.2. How we rate

Financial health

Weak: 41 out of 100. Higher than 12% of charities in its peer group (human services, $10m to $100m).

  • Reserves

    10 of 35

    Spendable reserves would cover 2.6 months of spending.

  • Debt

    16 of 20

    It owes 23% of what it owns.

  • Living within its means

    0 of 15

    Spending exceeded income by 38% of income.

  • Income trend

    0 of 15

    Income fell 32% on the year before.

  • Spending floor

    15 of 15

    81% of spending went to programs and raising each dollar of donations cost 0 cents.

Source: Form 990 for the year ending December 31, 2024, filed with the Internal Revenue Service. Rating method 2026.2. How we rate

Governance

Strong: 100 out of 100. Higher than 35% of charities in its peer group (human services, $10m to $100m).

  • Independent board

    25 of 25

    15 of 16 voting board members are independent.

  • Conflict of interest policy

    15 of 15

    Has a written conflict of interest policy.

  • Whistleblower policy

    8 of 8

    Has a written whistleblower policy.

  • Record keeping policy

    7 of 7

    Has a written policy on keeping and destroying records.

  • Board minutes

    5 of 5

    Keeps minutes of board meetings.

  • Board sees the tax return

    10 of 10

    Gave the board a copy of this return before filing it.

  • Pay set independently

    5 of 5

    Sets its chief executive's pay through independent review and comparison.

  • Independent check of accounts

    15 of 15

    Its accounts were audited by an independent accountant.

  • No reported misuse

    10 of 10

    Reports no diversion of assets, excess benefits or loans to insiders.

Source: Form 990 for the year ending December 31, 2024, filed with the Internal Revenue Service. Rating method 2026.2. How we rate

Impact evidence

Describes programs. Its tax return describes what it does but we have found no measurable results in it.

Programs described in its return (4)
  1. $4.4 million spent. RESEARCH ENGAGEMENT AND PREPAREDNESS: RESEARCH PREPAREDNESS IS DESIGNED TO SHAPE THE R&D ENVIRONMENT THROUGH ADVOCACY FOR INVESTMENT, POLITICAL SUPPORT, AND GOOD PARTICIPATORY PRACTICE. AVAC TRACKS AND TRANSLATES BOTH COMMUNITY ADVOCACY AND COMPLEX SCIENCE TO MAKE THE SCIENCE ACCESSIBLE AND POSITION COMMUNITY PRIORITIES AT THE CENTER OF GLOBAL HEALTH. AVAC IMPROVED TRIAL DESIGN AND CONDUCT BY BRINGING TOGETHER RESEARCHERS, TRIAL SITE STAFF, CIVIL SOCIETY, POLICYMAKERS, TRIAL PARTICIPANTS, AND COMMUNITIES TO CENTER PERSPECTIVES OF AFFECTED COMMUNITIES IN RESEARCH. AVAC DEVELOPED MATERIALS AND DOCUMENTS RELATING TO THE PREVENTION OF HIV/AIDS; CONVENED MULTIPLE MEETINGS WITH STAKEHOLDERS SUCH AS RESEARCHERS AND CIVIL SOCIETY LEADERS TO DISCUSS RESEARCH FINDINGS; PROGRAM SERVICE ACCOMPLISHMENTS.
  2. $2.2 million spent. PRODUCT INTRODUCTION AND ACCESS: THE PRODUCT INTRODUCTION PROGRAM IS DESIGNED TO IDENTIFY AND ANTICIPATE NEEDS AND GAPS AND PROVIDE TARGETED TOOLS, SUPPORT AND PLATFORMS TO EXPAND ACCESS TO HIV/AIDS PREVENTION. THE PROGRAM FOCUSES ON: SUCCESSFUL SCALE-UP AND INTRODUCTION IN THREE PRIORITY COUNTRIES FROM THE OUTSET; DEVELOP ADAPTABLE AND SCALABLE TOOLS TO SUPPORT OTHER COUNTRIES; SUPPORT THE DEVELOPMENT OF MARKETABLE PRODUCTS IN THE HIV PREVENTION AND SEXUAL AND REPRODUCTIVE HEALTH RESEARCH PIPELINE; AND CREATE A FLEXIBLE MECHANISM TO ASSIST PRODUCT DEVELOPERS, FUNDERS AND COUNTRY PROGRAMS TO IDENTIFY AND ADDRESS BARRIERS TO IMPROVED PRODUCTS AND ACCELERATED INTRODUCTION. PROJECTS ARE IMPLEMENTED IN COLLABORATION WITH A NETWORK OF FUNDERS, (CONTINUED ON SCHEDULE O)CONTINUED: PRODUCT DEVELOPERS AND GOVERNMENTAL AND NON-GOVERNMENTAL ORGANIZATIONS INCLUDING THE BILL AND MELINDA GATES FOUNDATION, CHILDRENS INVESTMENT FUND FOUNDATION, WORLD HEALTH ORGANIZATION, POPULATION COUNCIL, VIATRIS, MANN GLOBAL HEALTH, MEDICINES360, USAID, CATALYST GLOBAL, HIV PREVENTION TRIALS NETWORK, AND CLINTON HEALTH ACCESS INITATIVE.
  3. $1.5 million spent. GLOBAL MOVEMENT BUILDING: GLOBAL MOVEMENT BUILDING CULTIVATES THE NEXT GENERATION OF ADVOCATES VIA THE AVAC FELLOWS AND ADVOCACY NAVIGATOR PROGRAMS. ADVOCATES ARE EQUIPPED WITH THE SKILLS, OPPORTUNITIES AND ACCESS TO DRIVE CHANGE IN HIV PREVENTION AND GLOBAL HEALTH EQUITY BY AMPLIFYING COMMUNITY VOICES AND INFLUENCING POLICY AND RESEARCH. ALUMNI OF THESE PROGRAMS ARE LEADING, INTERNATIONALLY RECOGNIZED CIVIL SOCIETY ADVOCATES. THEY HAVE GONE ON TO FOUND CIVIL SOCIETY ORGANIZATIONS, INFLUENCE THE HIV PREVENTION RESEARCH PIPELINE, AND SHAPE CONVERSATIONS AND OBJECTIVES IN THE FIELD. AVAC ALSO SHAPES THE MEDIA ENVIRONMENT BY COLLABORATING CLOSELY WITH JOURNALIST CONVENERS TO BRING TOGETHER JOURNALISTS AND SCIENTISTS AT MEDIA SCIENCE CAFES. THROUGH THIS ENGAGEMENT WITH EXPERTS, (CONTINUED ON SCHEDULE O)CONTINUED: LOCAL JOURNALISTS HAVE DIRECT ACCESS TO ACCURATE DATA AND INFORMATION, ENABLING THEM TO TRANSLATE THE SCIENCE AND REPORT DIRECTLY TO LOCAL COMMUNITIES ON DEVELOPMENTS IN HIV BIOMEDICAL PREVENTION RESEARCH. THIS IMPROVES THE QUALITY AND ACCURACY OF REPORTING, COMBATS MISINFORMATION, AND BRINGS VISIBILITY TO RESEARCH DEVELOPMENTS.
  4. $3.1 million spent. PROGRAMS ARE POLICY ADVOCACY AND PROGRAM MANAGEMENT AND COMMUNICATIONS

Source: Form 990 for the year ending December 31, 2024, filed with the Internal Revenue Service. Rating method 2026.2. How we rate

Legitimacy checks

  1. Is it registered with the IRS? Passed.

    Listed in the IRS master file of tax-exempt organizations as a 501(c)(3) charitable organization.

    Source: Exempt Organizations Business Master File, Internal Revenue Service, file dated October 13, 2026.

  2. Has the IRS revoked its tax-exempt status? Passed.

    Not on the IRS automatic revocation list.

    Source: Automatic revocation of exemption list, Internal Revenue Service, file dated November 6, 2026.

  3. Are donations tax-deductible? Passed.

    On the IRS list of organizations eligible to receive tax-deductible contributions.

    Source: Publication 78 data: organizations eligible for tax-deductible contributions, Internal Revenue Service, file dated October 13, 2026.

  4. Is it keeping up with its IRS filings? Passed.

    Most recent return on file covers the year ending December 2024.

    Source: Exempt Organizations Business Master File, Internal Revenue Service, file dated October 13, 2026.

  5. How long has it been tax-exempt? Passed.

    Recognized by the IRS since April 1997.

    Source: Exempt Organizations Business Master File, Internal Revenue Service, file dated October 13, 2026.

  6. Is it in good standing with state regulators? Passed.

    Not on California's list of charities barred from soliciting. Other states are not yet checked.

    Source: May Not Operate or Solicit for Charitable Purposes list, California Attorney General, Registry of Charities and Fundraisers, file dated November 4, 2026.

Ratings and checks are our reading of public records, using the published method. They are not a statement about anyone's honesty. If you work for this organization, you can send corrections or results, confirm you want gifts through Veridonate, or ask to be removed from giving.